MECHANISMS OF ACTIVATION OF HEMATOPOIETIC RECOVERY DUE TO FILGASTRIM IN BREAST CANCER PATIENTS RECEIVING CHEMOTHERAPY WITH DOXORUBICIN/DOCETAXEL

The effect of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery was studied. The study included 77 patients with stage III–IV breast cancer who received chemotherapy with oxorubicin/docetaxel. Filgastrim was administered to 30 patients in the intervals be...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Т. Yu. Khrichkova, V. Е. Goldberg, N. О. Popova, Е. I. Simolina, Yu. V. Belevich, V. V. Zhdanov, L. А. Miroshnichenko, Е. V. Udut, Е. V. Simanina
Formato: Artigo
Lenguaje:Russo
Publicado: Tomsk National Research Medical Center of the Russian Academy of Sciences 2016-02-01
Colección:Sibirskij Onkologičeskij Žurnal
Materias:
breast cancer, chemotherapy, granulocytopoiesis, docetaxel, filgastrim
Acceso en línea:https://www.siboncoj.ru/jour/article/view/201
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares